<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04776512</url>
  </required_header>
  <id_info>
    <org_study_id>ESP versus Epidural analgesia</org_study_id>
    <nct_id>NCT04776512</nct_id>
  </id_info>
  <brief_title>Erector Spinae Plane Block Versus Classic Epidural Analgesia in Labor</brief_title>
  <official_title>Lumbar Erector Spinae Plane Block Versus Classic Epidural Analgesia in Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mongi Slim Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mongi Slim Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prosepective,Randomized, controlled study enrolling full termed parturients admitted for&#xD;
      vaginal delivery.&#xD;
&#xD;
      At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2&#xD;
      groups:&#xD;
&#xD;
        -  ESP group: patients will receive ultrasound guided, bilateral ESP Block performed at the&#xD;
           level of the 3 rd Lumbar transverse process.&#xD;
&#xD;
        -  Epidural Analgesia Group: Patients will have a classic lumbar continuous epidural&#xD;
           analgesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prosepective,Randomized, controlled study enrolling full termed parturients admitted for&#xD;
      vaginal delivery.&#xD;
&#xD;
      At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2&#xD;
      groups:&#xD;
&#xD;
        -  ESP group: patients will receive ultrasound guided, bilateral ESP Block performed at the&#xD;
           level of the 3 rd Lumbar transverse process.&#xD;
&#xD;
        -  Epidural Analgesia Group: Patients will have a classic lumbar continuous epidural&#xD;
           analgesia.&#xD;
&#xD;
      For the first group: 20 ml of 0,375% isobaric Bupivacain solution will be injected&#xD;
      bilaterally under ultrasound direct vision.&#xD;
&#xD;
      Concerning the second group, patients will have a continuous injection of 0,125% Bupivacain&#xD;
      solution associated to 0,25 mcg of Sufentanil/ml through an epidural catheter in the L3-L4 or&#xD;
      L4-L5 intervertebral space.&#xD;
&#xD;
      For the 2 groups, analgesia will be assessed during all the labor period hourly using the&#xD;
      Visual Analog pain Score (VAS).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia during labor</measure>
    <time_frame>change in VAS score 1 hour after the beginning of labor</time_frame>
    <description>analgesia assessed using VAScore</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Analgesia in Labor</condition>
  <arm_group>
    <arm_group_label>Epidural Analgesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients of this group Will receive an epidural analgesia through a lumbar epidural catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESP Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral ESP block performed at the level of the 3 rd Lumbar transverse process.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ESP Block With Bupivacain</intervention_name>
    <description>bilateral lumbar ESP block using 0.375% Bupivacain</description>
    <arm_group_label>ESP Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural Analgesia</intervention_name>
    <description>Continuous Lumbar Epidural analgesia With 0,125% Bupivacain+0,25 mcg/ml Sufentanil</description>
    <arm_group_label>Epidural Analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Full termed parturients admitted for vaginal delivery&#xD;
&#xD;
          -  singleton pregnancy&#xD;
&#xD;
          -  No contraindications to perimedullar analgesia techniques&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Indication to Cesarean section during labor period&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>full termed parturients</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mhamed Sami Mebazaa, Professor</last_name>
    <phone>0021622252589</phone>
    <email>msmebazaa@gamil.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ben Souissi Asma, As professor</last_name>
    <phone>0021698336883</phone>
    <email>bsouissiasma@gamil.com</email>
  </overall_contact_backup>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>February 26, 2021</last_update_submitted>
  <last_update_submitted_qc>February 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mongi Slim Hospital</investigator_affiliation>
    <investigator_full_name>Mhamed Sami Mebazaa</investigator_full_name>
    <investigator_title>Professor head of anesthesia and intensive care department</investigator_title>
  </responsible_party>
  <keyword>analgesia, vaginal delivery, ESP, EPIDURAL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

